A Linn Murphree
Overview
Explore the profile of A Linn Murphree including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stachelek K, Harutyunyan N, Lee S, Beck A, Kim J, Xu L, et al.
Genes Chromosomes Cancer
. 2022 Dec;
62(5):275-289.
PMID: 36550020
Retinoblastomas form in response to biallelic RB1 mutations or MYCN amplification and progress to more aggressive and therapy-resistant phenotypes through accumulation of secondary genomic changes. Progression-related changes include recurrent somatic...
2.
Berry J, Munier F, Gallie B, Polski A, Shah S, Shields C, et al.
Pediatr Blood Cancer
. 2021 Feb;
68(5):e28964.
PMID: 33624399
Standardized guidelines for assessing tumor response to therapy are essential for designing and conducting clinical trials. The Response Evaluation Criteria In Solid Tumors (RECIST) provide radiological standards for assessment of...
3.
Jubran R, Villablanca J, Krailo M, Piao J, Huang L, Murphree A, et al.
Pediatr Blood Cancer
. 2020 Jun;
67(9):e28502.
PMID: 32589362
Background: Eyes with Group D intraocular retinoblastoma have low salvage rates. A pilot study showed safety and efficacy of sub-Tenon's fascia carboplatin with systemic chemotherapy supporting further study. Methods: Children...
4.
Berry J, Polski A, Cavenee W, Dryja T, Murphree A, Gallie B
Genes (Basel)
. 2019 Nov;
10(11).
PMID: 31683923
The gene is the first described human tumor suppressor gene and plays an integral role in the development of retinoblastoma, a pediatric malignancy of the eye. Since its discovery, the...
5.
Kim J, Madi I, Lee R, Zolfaghari E, Jubran R, Lee T, et al.
Ophthalmol Retina
. 2019 May;
1(5):369-374.
PMID: 31047563
Purpose: The aim of this 8-year retrospective review was to determine the clinical significance of gadolinium-enhanced magnetic resonance imaging (MRI) findings in retinoblastoma patients after enucleation, particularly the presence of...
6.
Kim J, Aziz H, McGovern K, Zolfaghari E, Jubran R, Murphree A, et al.
Ophthalmol Retina
. 2019 May;
1(5):361-368.
PMID: 31047562
Purpose: To evaluate the ocular treatment outcomes of focal laser consolidation during systemic chemoreduction for Group B tumors in the posterior fundus. Design: Single-institution retrospective chart review from 1995 to ...
7.
Berry J, Kogachi K, Murphree A, Jubran R, Kim J
Int Ophthalmol Clin
. 2019 Mar;
59(2):65-75.
PMID: 30908280
No abstract available.
8.
Nguyen S, Sison J, Jones M, Berry J, Kim J, Murphree A, et al.
Int J Radiat Oncol Biol Phys
. 2018 Dec;
103(5):1143-1150.
PMID: 30537543
Purpose: We retrospectively assessed the incidence of cataracts in patients with retinoblastoma (Rb) treated with either lens-sparing radiation therapy (LSRT) or whole-eye radiation therapy (WERT). A secondary aim of this...
9.
Berry J, Xu L, Kooi I, Murphree A, Prabakar R, Reid M, et al.
Mol Cancer Res
. 2018 Aug;
16(11):1701-1712.
PMID: 30061186
Tumor-derived cell-free DNA (cfDNA) has biomarker potential; therefore, this study aimed to identify cfDNA in the aqueous humor (AH) of retinoblastoma eyes and correlate somatic chromosomal copy-number alterations (SCNA) with...
10.
Lang P, Kim J, McGovern K, Reid M, Subramanian K, Murphree A, et al.
Orbit
. 2018 Feb;
37(6):438-443.
PMID: 29461921
This study aims to identify risk factors associated with complications in retinoblastoma patients following primary and secondary enucleations with porous implant placement. A retrospective case-control study was performed between 2010...